Imvax
Imvax is a clinical-stage biotechnology company focused on the development of patient-specific vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers with unmet medical needs.
All edits
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-2 properties)
Infobox
Official Website
Official Website
Edits on 5 Apr, 2023
Katrina-Kay Pettitt
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 16 Feb, 2023
Golden AI
Edits made to:
Infobox (+2/-1 properties)
Infobox
Total Funding Amount (USD)
152,370,500
Latest Funding Round Amount (USD)
112,370,500
Total Funding Amount (USD)
192,370,500
Wyckliffe Otieno
Edits on 23 Dec, 2022
Golden AI
Golden AI
Paul Nutz
Edits made to:
Infobox (+3/-1 properties)
Infobox
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 22 Jul, 2022
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Phone number
215-485-0071
Phone number
+12154850071
Edits on 8 Jul, 2022
Andrey Duzenko
Infobox
CFO
Country
Founder
Location
Edits on 17 May, 2022
Katrina-Kay Pettitt
Edits on 6 May, 2022
Amy Sar
Edits on 28 Apr, 2022
Andrey Duzenko
Edits made to:
Infobox (+2 properties)
Infobox
Full address
601 Walnut Street, Suite 440W, Philadelphia, PA 19106
Edits on 5 Apr, 2022
Amy Sar
Edits made to:
Infobox (+4 properties)
Infobox
Edits on 6 Aug, 2021
Golden AI
Edits on 14 Jun, 2021
Erin Scherfner
Edits made to:
Infobox (+3 properties)
Infobox
Edits on 11 May, 2021
Golden AI
Find more companies like Imvax
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.